Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer

Journal of Geriatric Oncology

Volumn 4, Issue 3, 2013, Pages 227-234

  Wildes, Tanya M ^a   Ruwe, Alexander P ^a   Fournier, Chloe ^a   Gao, Feng ^a   Carson, Kenneth R ^a   Piccirillo, Jay F ^a   Tan, Benjamin ^a   Colditz, Graham A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cancer; Chemotherapy; Geriatric assessment; Geriatrics; Survival; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; BENDAMUSTINE; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; NAVELBINE; OXALIPLATIN; PEMETREXED; PREDNISONE; RITUXIMAB; TRASTUZUMAB; VINBLASTINE; VINCRISTINE;

AGE DISTRIBUTION; AGED; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; DAILY LIFE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GERIATRIC CARE; HEALTH STATUS; HUMAN; KIDNEY FUNCTION; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT WITHDRAWAL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GERIATRIC ASSESSMENT; HEMATOLOGIC DISEASES; HUMANS; LUNG NEOPLASMS; LYMPHOMA; MALE; MEDICATION ADHERENCE; NEOPLASMS; PATIENT PREFERENCE; PROSPECTIVE STUDIES;

EID: 84878965576     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2013.02.002     Document Type: Article

References (29)

1. Smith B.D., Smith G.L., Hurria A., Hortobagyi G.N., Buchholz T.A. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol Jun 8 2009, 27(17):2758-2765.
2. Bouchardy C., Rapiti E., Fioretta G., Laissue P., Neyroud-Caspar I., Schäfer P., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol Oct 1 2003, 21(19):3580-3587.
3. Sundararajan V., Hershman D., Grann V.R., Jacobson J.S., Neugut A.I. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol Jan 1 2002, 20(1):173-178.
4. Mahoney T., Kuo Y.H., Topilow A., Davis J.M. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg Feb 2000, 135(2):182-185.
5. Extermann M., Chen H., Cantor A.B., Corcoran M.B., Meyer J., Grendys E., et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer Jul 2002, 38(11):1466-1473.
6. Hurria A., Togawa K., Mohile S.G., Owusu C., Klepin H.D., Gross C.P., et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol Aug 30 2011, 29(25):3457-3465.
7. Extermann M., Boler I., Reich R.R., Lyman G.H., Brown R.H., DeFelice J., et al. Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer Jul 1 2012, 118(13):3377-3386.
8. Hurria A., Cirrincione C.T., Muss H.B., Kornblith A.B., Barry W., Artz A.S., et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 2011, 29(10):1290-1296.
9. Dobie S.A., Baldwin L.-M., Dominitz J.A., Matthews B., Billingsley K., Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst May 3 2006, 98(9):610-619.
10. Soubeyran P., Fonck M., Blanc-Bisson C., Blanc J.-F., Ceccaldi J., Mertens C., et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol May 20 2012, 30(15):1829-1834.
11. Hann D., Winter K., Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the center for epidemiological studies depression scale (Ces-d). J Psychosom Res 1999, 46(5):437-443. [Elsevier].
12. Fick D.M., Cooper J.W., Wade W.E., Waller J.L., Maclean J.R., Beers M.H. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med Nov 2003, 163(22):2716-2724.
13. Katzman R., Brown T., Fuld P., Peck A., Schechter R., Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry Jun 1983, 140(6):734-739.
14. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol Dec 1982, 5(6):649-655.
15. Katz S., Ford A.B., Moskowitz R., Jackson B., Jaffe M. Studies of Illness in the Aged: The Index of ADL. JAMA 1963, 185:914-919.
16. Lawton M., Brody E. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9(3):179-986.
17. Rubenstein L.Z., Harker J.O., Salvà A., Guigoz Y., Vellas B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci Jun 2001, 56(6):M366-M372.
18. Piccirillo J.F., Creech C.M., Zequeira R., Anderson S., Johnston A.S. Inclusion of comorbidity into oncology data registries. J Registry Manag 1999, 26(2):66-70.
19. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med Aug 15 2006, 145(4):247-254.
20. Frasci G., Lorusso V., Panza N., Comella P., Nicolella G., Bianco A., et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol Jul 2000, 18(13):2529-2536.
21. Fairfield K.M., Murray K., Lucas F.L., Wierman H.R., Earle C.C., Trimble E.L., et al. Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer. J Clin Oncol Oct 10 2011, 29(29):3921-3926.
22. Freyer G., Geay J.-F., Touzet S., Provencal J., Weber B., Jacquin J.-P., et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol Nov 2005, 16(11):1795-1800.
23. Landi F., Liperoti R., Russo A., Giovannini S., Tosato M., Capoluongo E., et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr Mar 11 2012, 1-7. [epub].
24. Hubbard R.E., O'Mahony M.S., Savva G.M., Calver B.L., Woodhouse K.W. Inflammation and frailty measures in older people. J Cell Mol Med Sep 2009, 13(9B):3103-3109.
25. Krakauer J.C., Franklin B., Kleerekoper M., Karlsson M., Levine J.A. Body composition profiles derived from dual-energy X-ray absorptiometry, total body scan, and mortality. Prev Cardiol 2004, 7(3):109-115.
26. Peduzzi P., Concato J., Kemper E., Holford T.R., Feinstein A.R. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol Dec 1996, 49(12):1373-1379.
27. Vittinghoff E., McCulloch C.E. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol Mar 15 2007, 165(6):710-718.
28. Kallogjeri D., Piccirillo J.F., Spitznagel E.L., Steyerberg E.W. Comparison of scoring methods for ACE-27: simpler is better. J Geriatr Oncol Jul 1 2012, 3(3):238-245.
29. Repetto L., Fratino L., Audisio R.A., Venturino A., Gianni W., Vercelli M., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol Jan 15 2002, 20(2):494-502.